Homoarginine and mortality in an older population: The Hoorn study

European Journal of Clinical Investigation

Volumn 44, Issue 2, 2014, Pages 200-208

  Pilz, Stefan ^a,b   Teerlink, Tom ^c   Scheffer, Peter G ^c   Meinitzer, Andreas ^b   Rutters, Femke ^a   Tomaschitz, Andreas ^b   Drechsler, Christiane ^d   Kienreich, Katharina ^b   Nijpels, Giel ^a   Stehouwer, Coen D A ^e   März, Winfried ^b,f,g   Dekker, Jacqueline M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g SYNLAB ACADEMY   (Germany)

Author keywords

AMINO acids; Cardiovascular; Homoarginine; Mortality; Prospective

Indexed keywords

HOMOARGININE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID DEFICIENCY; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CAUSE SPECIFIC MORTALITY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; OVERALL MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; AGE; BLOOD; DEFICIENCY; EPIDEMIOLOGY; MIDDLE AGED; NETHERLANDS;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; HOMOARGININE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS;

EID: 84892479071     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12208     Document Type: Article

References (39)

1. Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 2009;37:1-17.
2. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, et al. Homoarginine, cardiovascular risk, and mortality. Circulation 2010;122:967-75.
3. Pilz S, Tomaschitz A, Meinitzer A, Drechsler C, Ritz E, Krane V, et al. Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 2011;42:1132-4.
4. Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, Krane V, et al. Low homoarginine concentration is a novel risk factor for heart disease. Heart 2011;97:1222-7.
5. Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, et al. Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 2011;13:852-9.
6. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Dobnig H, Schwarz M, et al. Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients. Osteoporos Int 2013;24:377-81.
7. Atzler D, Rosenberg M, Anderssohn M, Choe CU, Lutz M, Zugck C, et al. Homoarginine - An independent marker of mortality in heart failure. Int J Cardiol 2013;168:4907-9.
8. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JS, et al. Serum L-homoarginine is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 2008;72:1879-84.
9. Meinitzer A, Drechsler C, Tomaschitz A, Pilz S, Krane V, Wanner C, et al. Homoarginine: a new cardiovascular risk marker in hemodialysis patients. J Lab Med 2011;35:153-9.
10. Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 1998;37:10453-60.
11. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993;22:812-8.
12. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-7.
13. Henningsson R, Lundquist I. Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol 1998;275:E500-6.
14. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Fahrleitner-Pammer A, Drechsler C, et al. Homoarginine deficiency is associated with increased bone turnover. Osteoporos Int 2012;23:2731-2.
15. Davids M, Ndika JD, Salomons GS, Blom HJ, Teerlink T. Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett 2012;586:3653-7.
16. Ryan WL, Johnson RJ, Dimari S. Homoarginine synthesis by rat kidney. Arch Biochem Biophys 1969;131:521-6.
17. Rao SL. A look at the brighter facets of β-N-oxalyl-l-α, β-diaminopropionic acid, homoarginine and the grass pea. Food Chem Toxicol 2011;49:620-2.
18. Kleber ME, Seppälä I, Pilz S, Hoffmann MM, Tomaschitz A, Oksala N, et al. Genome-Wide Association Study Identifies 3 Genomic Loci Significantly Associated With Serum Levels of Homoarginine: The AtheroRemo Consortium. Circ Cardiovasc Genet 2013;6:505-13.
19. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, et al. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 2006;114:16-20.
20. van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouwer CD, Teerlink T. L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 2013;31:1114-23.
21. van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, et al. Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr 2007;85:755-61.
22. Pilz S, van den Hurk K, Nijpels G, Stehouwer CD, Van't Riet E, Kienreich K, et al. Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: the Hoorn study. Nutr Metab Cardiovasc Dis 2012;22:883-9.
23. Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009;71:666-72.
24. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002;303:131-7.
25. de Jong S, Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 2006;353:287-9.
26. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54.
27. Choe CU, Atzler D, Wild PS, Carter AM, Böger RH, Ojeda F, et al. Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 2013;128:1451-61.
28. Ravani P, Maas R, Malberti F, Pecchini P, Mieth M, Quinn R, et al. Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients. PLoS One 2013;8:e72694.
29. Drechsler C, Kollerits B, Meinitzer A, März W, Ritz E, König P, et al. Homoarginine and progression of chronic kidney disease: results from the mild to moderate kidney disease study. PLoS One 2013;8:e63560.
30. Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, et al. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 2011;57:112-21.
31. Kakoki M, Kim HS, Arendshorst WJ, Mattson DL. L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla. Am J Physiol Regul Integr Comp Physiol 2004;287:R1478-85.
32. Khalil AA, Tsikas D, Akolekar R, Jordan J, Nicolaides KH. Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study. J Hum Hypertens 2013;27:38-43.
33. da Silva RP, Nissim I, Brosnan ME, Brosnan JT. Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am J Physiol Endocrinol Metab 2009;296:E256-61.
34. McClure WC, Rabon RE, Ogawa H, Tseng BS. Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice. Neuromuscul Disord 2007;17:639-50.
35. Edvardson S, Korman SH, Livne A, Shaag A, Saada A, Nalbandian R, et al. l-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation. Mol Genet Metab 2010;101:228-32.
36. Ndika JD, Johnston K, Barkovich JA, Wirt MD, O'Neill P, Betsalel OT, et al. Developmental progress and creatine restoration upon long-term creatine supplementation of a patient with arginine:glycine amidinotransferase deficiency. Mol Genet Metab 2012;106:48-54.
37. Choe CU, Nabuurs C, Stockebrand MC, Neu A, Nunes P, Morellini F, et al. L-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome. Hum Mol Genet 2013;22:110-23.
38. Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002;287:1420-6.
39. Savvidou MD, Hingorani AD, Tsikas D, Frölich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003;361:1511-7.